1. Home
  2. CMCSA vs VRTX Comparison

CMCSA vs VRTX Comparison

Compare CMCSA & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comcast Corporation

CMCSA

Comcast Corporation

HOLD

Current Price

$30.15

Market Cap

97.9B

ML Signal

HOLD

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

HOLD

Current Price

$469.70

Market Cap

115.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCSA
VRTX
Founded
1963
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
EDP Services
Sector
Telecommunications
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
97.9B
115.7B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
CMCSA
VRTX
Price
$30.15
$469.70
Analyst Decision
Buy
Buy
Analyst Count
19
28
Target Price
$35.01
$537.64
AVG Volume (30 Days)
22.1M
1.3M
Earning Date
01-01-0001
05-15-2026
Dividend Yield
4.38%
N/A
EPS Growth
N/A
836.54
EPS
N/A
15.32
Revenue
N/A
$2,488,652,000.00
Revenue This Year
$1.78
$10.79
Revenue Next Year
N/A
$10.14
P/E Ratio
$5.86
$31.19
Revenue Growth
N/A
46.20
52 Week Low
$25.75
$362.50
52 Week High
$37.72
$517.20

Technical Indicators

Market Signals
Indicator
CMCSA
VRTX
Relative Strength Index (RSI) 42.30 47.40
Support Level $27.41 $428.47
Resistance Level $30.35 $473.78
Average True Range (ATR) 0.73 16.34
MACD -0.23 -0.85
Stochastic Oscillator 5.00 31.94

Price Performance

Historical Comparison
CMCSA
VRTX

About CMCSA Comcast Corporation

Comcast is made up of three parts. The core cable business owns networks capable of providing television, internet access, and phone services to 65 million US homes and businesses, or nearly half of the country. The firm provides services to about half of the locations in this territory. Comcast acquired NBCUniversal from General Electric in 2011. NBCU owns several cable networks, including CNBC, MSNBC, and USA, the NBC network, the Peacock streaming platform, several local NBC affiliates, Universal Studios, and several theme parks. The firm plans to spin off most of its cable networks. Finally, Sky, acquired in 2018, is a large television provider in the UK and Italy.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: